Relay Therapeutics is trading at $19.50, up 5.8% in pre-market, as the stock rebounds from a recent pullback in line with a broader risk-on move in U.S. equities.
- The recovery follows a 4.1% decline on July 24, which was driven by general market volatility rather than any company-specific catalysts.
- With major indices and futures trading solidly higher, the stock is benefiting from improved sentiment despite a lack of fresh corporate news.